JP2011509281A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509281A5
JP2011509281A5 JP2010541823A JP2010541823A JP2011509281A5 JP 2011509281 A5 JP2011509281 A5 JP 2011509281A5 JP 2010541823 A JP2010541823 A JP 2010541823A JP 2010541823 A JP2010541823 A JP 2010541823A JP 2011509281 A5 JP2011509281 A5 JP 2011509281A5
Authority
JP
Japan
Prior art keywords
homeoprotein
composition according
retinal ganglion
family
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010541823A
Other languages
English (en)
Other versions
JP5851692B2 (ja
JP2011509281A (ja
Filing date
Publication date
Priority claimed from FR0800110A external-priority patent/FR2926023B1/fr
Application filed filed Critical
Publication of JP2011509281A publication Critical patent/JP2011509281A/ja
Publication of JP2011509281A5 publication Critical patent/JP2011509281A5/ja
Application granted granted Critical
Publication of JP5851692B2 publication Critical patent/JP5851692B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (5)

  1. 網膜神経節ニューロン変性の予防又は治療のための、ビコイドファミリーのホメオタンパク質を含む医薬組成物
  2. 前記網膜神経節ニューロン変性が緑内障において生じることを特徴とする請求項1に記載の医薬組成物
  3. 培養網膜神経節ニューロンの生存を増大させるための、ビコイドファミリーのホメオタンパク質を含む組成物
  4. 前記ホメオタンパク質がOtxサブファミリーに属することを特徴とする請求項1〜3のいずれか1項に記載の組成物
  5. 前記ホメオタンパク質がOtx2ホメオタンパク質であることを特徴とする請求項4に記載の組成物
JP2010541823A 2008-01-09 2009-01-09 網膜神経節ニューロン変性を予防又は治療するためのビコイドファミリーのホメオタンパク質の使用 Active JP5851692B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0800110A FR2926023B1 (fr) 2008-01-09 2008-01-09 Utilisation d'une homoproteine de la famille bicoid pour le traitement du glaucome.
FR0800110 2008-01-09
PCT/FR2009/000031 WO2009106767A2 (fr) 2008-01-09 2009-01-09 Utilisation d'une homeoproteine de la famille bicoïd pour la prevention ou le traitement de la degenerescence des neurones ganglionnaires retiniens

Publications (3)

Publication Number Publication Date
JP2011509281A JP2011509281A (ja) 2011-03-24
JP2011509281A5 true JP2011509281A5 (ja) 2012-02-23
JP5851692B2 JP5851692B2 (ja) 2016-02-03

Family

ID=39620167

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010541823A Active JP5851692B2 (ja) 2008-01-09 2009-01-09 網膜神経節ニューロン変性を予防又は治療するためのビコイドファミリーのホメオタンパク質の使用

Country Status (10)

Country Link
US (1) US10722554B2 (ja)
EP (1) EP2240197B1 (ja)
JP (1) JP5851692B2 (ja)
CA (1) CA2711866C (ja)
DK (1) DK2240197T3 (ja)
ES (1) ES2542518T3 (ja)
FR (1) FR2926023B1 (ja)
PL (1) PL2240197T3 (ja)
PT (1) PT2240197E (ja)
WO (1) WO2009106767A2 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2941230B1 (fr) * 2009-01-19 2011-03-18 Centre Nat Rech Scient Polypeptides d'adressage specifique a des cellules-cibles d'otx2
PL3352777T3 (pl) 2015-09-23 2022-02-07 Centre National De La Recherche Scientifique Engrailed do stosowania w leczeniu uszkodzenia dna u pacjentów cierpiących na chorobę parkinsona

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002325571A (ja) * 2001-04-27 2002-11-12 Purotekku:Kk 網膜の分化誘導方法
CN1747744B (zh) * 2003-02-03 2011-07-27 独立行政法人科学技术振兴机构 使用otx2基因再生和新生视网膜感光细胞
US7541186B2 (en) * 2006-02-22 2009-06-02 University Of Washington Method of generating human retinal progenitors from embryonic stem cells
US9243226B2 (en) * 2007-02-23 2016-01-26 University Of Central Florida Research Foundation, Inc. Biasing of cells toward retinal, corneal or lens development
FR2941230B1 (fr) * 2009-01-19 2011-03-18 Centre Nat Rech Scient Polypeptides d'adressage specifique a des cellules-cibles d'otx2

Similar Documents

Publication Publication Date Title
IL246181A0 (en) Methods for the preparation of retinal pigment epithelial cells, preparations containing them and their use for the preparation of drugs for the treatment or prevention of conditions characterized by retinal degeneration
WO2013103919A3 (en) Compositions and methods for treating metabolic disorders
TN2012000428A1 (en) Bisaryl-bonded aryltriazolones and use thereof
HN2011002406A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
MY171920A (en) Prevention and treatment of ocular conditions
PH12015500301A1 (en) A novel formulation of diclofenac
JP2012092110A5 (ja)
WO2012093234A3 (fr) Arabinogalactanes sulfates, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
WO2017070647A8 (en) Nicotinamide for use in the treatment and prevention of ocular neurodegenerative disorder (e.g. glaucoma)
DK3045456T3 (da) Bicyklisk substituerede uraciler og anvendelse heraf
WO2008149802A1 (ja) アンドログラホリドを有効成分とする抗疲労剤及び経口組成物
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
ES2524385R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento y la prevención de enfermedades causadas por el VIH
JP2013523758A5 (ja)
JP2010001264A5 (ja)
WO2012017435A3 (en) Soybean extracts for the treatment of hepatic disorders
JP2011509281A5 (ja)
JP2017061488A5 (ja)
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
WO2013073998A3 (ru) Новые производные гемина с антибактериальной и противовирусной активностью
WO2014043243A3 (en) Platinum compounds, compositions and methods for the treatment of cancer
JP2015500340A5 (ja)
WO2010142400A3 (de) Zusammensetzungen auf basis von chitosan-oligosacchariden
WO2010086617A3 (en) Phosphoantigens for the treatment of burkholderia infections
WO2009106767A3 (fr) Utilisation d'une homeoproteine de la famille bicoïd pour la prevention ou le traitement de la degenerescence des neurones ganglionnaires retiniens